Company Filing History:
Years Active: 2011
Title: Alexander James Floyd Thomas: Innovator in Hepatitis C Treatment
Introduction
Alexander James Floyd Thomas is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis C. His innovative work has led to the development of a unique compound that holds promise for patients suffering from this viral infection.
Latest Patents
Alexander holds a patent for "Biphenyl derivatives and their use in treating hepatitis C." This patent describes the use of a compound that is a biphenyl derivative of formula (I), or a pharmaceutically acceptable salt thereof, for the treatment of hepatitis C. The variables and specific applications of this compound are detailed within the patent documentation. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Alexander is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is instrumental in the ongoing fight against hepatitis C, a disease that affects millions worldwide.
Collaborations
Throughout his career, Alexander has worked alongside talented colleagues, including Christopher James Wheelhouse and David John Bushnell. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
In summary, Alexander James Floyd Thomas is a dedicated inventor whose work in developing biphenyl derivatives for hepatitis C treatment exemplifies the impact of innovation in medicine. His contributions continue to inspire advancements in pharmaceutical research and development.